BIOTECH NAVARRA DE INVESTIGACION SL
Company details
- Defunct NIF/CIF: B31775786
-
-
-
-
Address: AVENIDA CARLOS III, nº 36-1º DERECHA, PAMPLONA (PAMPLONA) See in map
-
-
Featured products:
More information on BIOTECH NAVARRA DE INVESTIGACION SL
-
24/01/2005 | BORME act no.: 29092 | Register: NAVARRACeses/Dimisiones
-
24/01/2005 | BORME act no.: 29092 | Register: NAVARRANombramientos
-
24/01/2005 | BORME act no.: 29092 | Register: NAVARRAModificaciones estatutarias
-
24/01/2005 | BORME act no.: 29092 | Register: NAVARRADisolución
-
16/07/2003 | BORME act no.: 285613 | Register: NAVARRADeclaración de unipersonalidad
-
03/04/2003 | BORME act no.: 140890 | Register: NAVARRAConstitución
-
03/04/2003 | BORME act no.: 140890 | Register: NAVARRANombramientos
Other information
The CIF of BIOTECH NAVARRA DE INVESTIGACION SL is B31775786 and its current status in the market is defunct. The company operates in the economic sector corresponding to the CNAE 8690 - Other health activities. As for its SIC, it is -.
BIOTECH NAVARRA DE INVESTIGACION SL employs approximately Between 10 and 49 employees and generates annual revenues of less than 2 million euros. The company is registered in the Mercantile Registry of Navarra and has a total of 2 registered positions. Its most recent announcement in the Borme is from 24/01/2005, while its last filing of ordinary annual accounts corresponds to the year -.
To obtain contact information for BIOTECH NAVARRA DE INVESTIGACION SL, such as phone number, postal address, or website, please refer to the Company Data section.
If you would like more details about BIOTECH NAVARRA DE INVESTIGACION SL, you can review one of our available financial reports, the company's annual accounts, or check its default incidents in the RAI delinquency register.
All the financial, commercial, and legal information we provide about BIOTECH NAVARRA DE INVESTIGACION SL comes from official sources and is regularly updated.
Do you want to know more about BIOTECH NAVARRA DE INVESTIGACION SL??
Find out more about this company by consulting these reports: